Melanoma - Competitive Landscape to 2026
Summary
GlobalDatas "Melanoma - Competitive Landscape to 2026" combines data from the Pharma Intelligence Center with in-house analyst expertise to provide a competitive assessment of the disease marketplace.
PD-1 targeting immunotherapies are the major focus of drug developers. There are 689 drugs in the pipeline, 47 of which targets PD-1. Big pharma dominates R&D in this indication, with BMS, Roche, Novartis, GSK, Merck & Co. and Pfizer leading the way. Increasing incidence expected to drive the growth in Melanoma market.
This reports provides a data-driven overview of the current and future competitive landscape in melanoma therapeutics.
Scope
Components of the report include -
- Disease epidemiology
- Marketed drugs assessment
- Pipeline drugs assessment
- Clinical trials assessment
- Commercial assessment
- Social media overview
- Digital marketing overview
Reasons to Buy
- Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
- Develop business strategies by understanding the trends shaping and driving the global melanoma market.
- Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the global melanoma market in the future.
- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
- Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments, and strategic partnerships.
1.1 Preface
1.2 Abbreviations
1.3 Related Reports
1.4 Upcoming Related Reports
2 Executive Summary
2.1 Key Findings
2.2 Key Events
3 Introduction
3.1 Report Scope
3.2 Disease Overview Epidemiology Overview
3.3 Epidemiology
4 Marketed Drugs Assessment
4.1 Marketed Drugs Overview
4.2 Marketed Drug Profiles
5 Pipeline Assessment
5.1 Pipeline Overview
5.2 Pipeline Breakdown by Region
5.3 Pipeline Breakdown by Molecule Type and Target
5.4 Drug Review Designations
5.5 Phase Transition Success Rates
5.6 Likelihood of Approval
6 Clinical Trial Assessment
6.1 Clinical Trials Overview by Phase
6.2 Overview by Region
6.4 Therapy Area Perspective
6.4 Leading Sponsors
6.5 Enrollment Analytics
6.6 Feasibility Analysis
7 Commercial Assessment
7.1 Upcoming Market Catalysts
8 Social Media and Digital Marketing
8.1 Key Twitter Chatter
8.2 Top Branded Websites
8.3 Trust Flow and Citation Flow
9 Appendix
9.1 Methodology
9.2 About the Authors
9.3 About GlobalData
9.4 Contact Us
9.5 Disclaimer
Melanoma - Global Drug Forecast and Market Analysis to 2029
Melanoma - Global Drug Forecast and Market Analysis to 2029Melanoma of the skin is a serious and aggressive form of cancer originating from melanocytes, the pigment cells in skin, and
USD 10995 View ReportCells Expressing Melanoma Associated Antigen 4 (Cancer/Testis Antigen 1.4 or MAGE 4 Antigen or MAGE 41 Antigen or MAGE X2 Antigen or MAGEA4) - Drugs in Development, 2021
Cells Expressing Melanoma Associated Antigen 4 (Cancer/Testis Antigen 1.4 or MAGE 4 Antigen or MAGE 41 Antigen or MAGE X2 Antigen or MAGEA4) - Drugs in Development, 2021Cells Expressing Melanoma
USD 3000 View ReportMelanoma - Global Drug Forecast and Market Analysis to 2029
Melanoma - Global Drug Forecast and Market Analysis to 2029Melanoma of the skin is a serious and aggressive form of cancer originating from melanocytes, the pigment cells in skin, and
USD 10995 View ReportGouty Arthritis (Gout) - Competitive Landscape in 2021
Gouty Arthritis (Gout) - Competitive Landscape in 2021GlobalDatas Gouty Arthritis (Gout) - Competitive Landscape in 2021 combines data from the Pharma Intelligence Center with in-house analyst expertise to provide a
USD 3495 View ReportFill The Form For Sample Request